Curanex Pharmaceuticals Inc
CURX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002025942
No open-market purchases or sales by Curanex Pharmaceuticals Inc insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $89.0K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Curanex Pharmaceuticals Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +1 vs. Q3 2025
- Shares held
- 425.1K
- +139.0K (+48.6%) vs. Q3 2025
- Total value
- $140.5K
- −$65.9K (−31.9%) vs. Q3 2025
- New holders
- 6
- 1 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CURX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $89.0K |
| Q1 2026 | 8 | $167.6K |
| Q4 2025 | 11 | $140.5K |
| Q3 2025 | 10 | $206.3K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Curanex Pharmaceuticals Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 104,278 | $34.5K | 0.00% | +40,211+62.8% | Added |
| DRW Securities, LLC | 71,553 | $23.7K | 0.00% | +71,553 | New |
| Two Sigma Investments, LP | 61,102 | $20.2K | 0.00% | +61,102 | New |
| Renaissance Technologies LLC | 59,297 | $19.6K | 0.00% | +59,297 | New |
| XTX Topco Ltd | 42,385 | $14.0K | 0.00% | +42,385 | New |
| Jane Street Group, LLC | 24,990 | $8.26K | 0.00% | −10,287−29.2% | Reduced |
| Geode Capital Management, LLC | 18,670 | $6.17K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 17,451 | $5.78K | 0.00% | −9,749−35.8% | Reduced |
| UBS Group AG | 12,991 | $4.30K | 0.00% | −51,525−79.9% | Reduced |
| HRT Financial LP | 12,378 | $4.00K | 0.00% | +12,378 | New |
| Bank of America Corp | 34 | $11 | 0.00% | +34 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −32,435−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,154−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −14,480−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −4,594−100.0% | Sold out |